Status:
UNKNOWN
Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases
Lead Sponsor:
Chengdu PLA General Hospital
Conditions:
Chronic Rheumatic Diseases
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic rheumatic disease
Eligibility Criteria
Inclusion
- were between 18 and 35 years of age
- without use of TCM in the previous 3 months
- and had a Steinbrocker functional status of class I, II, or III
Exclusion
- previous general health conditions disallowed their use of TCM
- were pregnant
- lack of motivation, remote from home, time-consuming,intervention, or other personal difficulties
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02260323
Start Date
October 1 2014
End Date
February 1 2022
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Chengdu Military Area Command PLA
Chengdu, Sichuan, China, 610083